Biochemical and Biophysical Research Communications
Volume 167, Issue 3, 30 March 1990, Pages 1022-1029
Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils
References (20)
- et al.
Biochem. Biophys. Res. Commun
(1984) - et al.
J. Biol. Chem
(1985) - et al.
Biochem. Biophys. Res. Commun
(1986) - et al.
Biochem. Biophys. Res. Commun
(1984) - et al.
J. Biol. Chem
(1985) - et al.
J. Biol. Chem
(1985) - et al.
J. Biol. Chem
(1986) - et al.
Cell
(1986) - et al.
J. Biol. Chem
(1986) - et al.
J. Biol. Chem
(1979)
There are more references available in the full text version of this article.
Cited by (46)
Lipid Mediators and Lung Function
2015, Comparative Biology of the Normal Lung: Second EditionInflammation and immune regulation by 12/15-lipoxygenases
2006, Progress in Lipid ResearchCitation Excerpt :They were since found to be generated in humans in vivo during cell–cell interactions and in diverse tissues, with their diminished production observed in several human diseases [121]. Lipoxins possess numerous anti-inflammatory bioactivities towards neutrophils, including inhibition of chemotaxis, adhesion, migration, superoxide generation, MAC1 expression, and IP3 formation [124–133]. An extensive review of this area can be found in Ref. [121].
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
2005, Prostaglandins Leukotrienes and Essential Fatty AcidsTotal synthesis of aspirin-triggered 15-epi-lipoxin A<inf>4</inf>
2001, Tetrahedron LettersTotal synthesis of lipoxin A<inf>4</inf> and lipoxin B<inf>4</inf> from butadiene
2000, Tetrahedron Letters
Copyright © 1990 Published by Elsevier Inc.